Related references
Note: Only part of the references are listed.Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction
Melda Turkoglu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy
Maria Giannouli et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey
Canan Kulah et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan
Cheng-Chih Lin et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2010)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Alexandre Prehn Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii
Joon Young Song et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
F. G. Rios et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study
H. Kallel et al.
INTENSIVE CARE MEDICINE (2007)
Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii
Said Motaouakkil et al.
JOURNAL OF INFECTION (2006)
Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia
Peter K. Linden et al.
CLINICAL INFECTIOUS DISEASES (2006)
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units
F Timurkaynak et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
F Ratjen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections:: clinical outcome and adverse events
N Petrosillo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin:: A comparison with imipenem-susceptible VAP
J Garnacho-Montero et al.
CLINICAL INFECTIOUS DISEASES (2003)
Comparative evaluation of three commercial software packages for analysis of DNA polymorphism patterns
A Rementeria et al.
CLINICAL MICROBIOLOGY AND INFECTION (2001)
Share Paper
